STK33 抗体 (AA 60-429)
Our Local Distributor
北京 101111
Quick Overview for STK33 抗体 (AA 60-429) (ABIN7875995)
抗原
See all STK33 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 60-429
-
原理
- STK33 Antibody / Serine/threonine-protein kinase 33
-
纯化方法
- Immunogen affinity purified
-
免疫原
- E.coli-derived human STK33 recombinant protein (Position: K60-Q429) was used as the immunogen for the STK33 antibody.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal dilution of the STK33 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL
-
缓冲液
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- After reconstitution, the STK33 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- STK33 (serine/threonine Kinase 33 (STK33))
-
别名
- STK33
-
背景
-
The STK33 antibody targets Serine/threonine-protein kinase 33, a cytoplasmic kinase encoded by the STK33 gene. Serine/threonine-protein kinase 33 phosphorylates cytoskeletal and signaling proteins to regulate apoptosis, spermatogenesis, and metabolic processes. Although its precise substrates remain under investigation, STK33 is involved in kinase cascades that control cell survival and stress adaptation. The STK33 antibody enables researchers to explore kinase signaling, protein phosphorylation, and pathways relevant to oncogenesis and germ-cell differentiation.
Serine/threonine-protein kinase 33 belongs to the calcium/calmodulin-dependent kinase superfamily and contains a conserved catalytic domain typical of serine/threonine kinases. It localizes mainly in the cytoplasm but may associate with actin filaments and mitochondria under stress conditions. The STK33 antibody allows localization analysis to assess how cellular context affects its distribution and activity. In germ cells, STK33 plays a role in sperm flagellum assembly and maturation, supporting reproductive function.
Aberrant activation of Serine/threonine-protein kinase 33 has been associated with tumor progression in various cancers, including leukemia, glioma, and pancreatic carcinoma. The STK33 antibody supports research into these roles by enabling detection of protein levels in tumor tissues and evaluating the impact of genetic silencing or kinase inhibition. Some studies have suggested STK33 as a synthetic lethal partner with KRAS mutations, linking it to targeted cancer therapy exploration.
Beyond oncology, Serine/threonine-protein kinase 33 contributes to cytoskeletal organization and stress responses. It may phosphorylate structural proteins that stabilize actin networks and maintain cellular morphology. The STK33 antibody enables analysis of these cytoskeletal effects and supports biochemical assays aimed at identifying STK33 substrates and binding partners. Its expression has also been noted in cardiac and skeletal muscle, indicating a potential role in contractile function.
The STK33 antibody performs effectively in western blotting, immunofluorescence, and immunohistochemistry, displaying cytoplasmic staining consistent with its kinase activity. NSJ Bioreagents provides this antibody as a validated reagent for use in molecular biology, oncology, and developmental studies. By supporting detailed analysis of Serine/threonine-protein kinase 33, the STK33 antibody advances understanding of kinase signaling, cytoskeletal regulation, and disease mechanisms related to cellular stress and proliferation. -
UniProt
- Q9BYT3
抗原
-